Search results
- 11.75Add to watchlist-0.30 (-2.49%)At close:4:00 PM EDTThu. May 30, 202411.75 0.00 (0.00%)After hrs:6:45 PM EDTThu. May 30, 2024Nasdaq Real Time Price (USD) · Market closed
- Open12.08High12.70Low11.62
- Mkt Cap12.15MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close12.0552 Wk. Low3.9552 Wk. High1,130.40
Top storiesIs Avalo Therapeutics (AVTX) Stock Outpacing Its Medical Peers This Year?Yahoo Finance · 1 week agoRelated stocks
Find the latest Avalo Therapeutics, Inc. (AVTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Price/Book (mrq) 1.66 . Enterprise ...
- GPRE
Find the latest Green Plains Inc. (GPRE) stock quote,...
- Sustainability
See Avalo Therapeutics, Inc. (AVTX) Environment, Social and...
- Chart
Interactive Chart for Avalo Therapeutics, Inc. (AVTX),...
- Financials
Get the detailed quarterly/annual income statement for Avalo...
- Profile
See the company profile for Avalo Therapeutics, Inc. (AVTX)...
- SEC Filings
Find the latest Avalo Therapeutics, Inc. (AVTX) stock quote,...
- GPRE
May 22, 2024 · 20.83%. $20.45M. Omni Health Inc. 0.00%. AVTX | Complete Avalo Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Get the latest Avalo Therapeutics Inc (AVTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
People also ask
What does avtx stand for?
Does avtx pay a dividend?
When will avtx stock trade on the NASDAQ Capital Market?
Does Avalo Therapeutics (avtx) pay a dividend?
Mar 28, 2024 · Discover real-time Avalo Therapeutics, Inc. Common Stock (AVTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
- $178.57
- Biotechnology: Pharmaceutical Preparations
- NASDAQ-CM
- Health Care
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates. Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into 2027 WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE ...
- 12.55 x 100
- 11.46
- 11.92 x 100
- 11.63
May 22, 2024 · A high-level overview of Avalo Therapeutics, Inc. (AVTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
View the latest Avalo Therapeutics Inc. (AVTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.